Aditya Khandelwal 
Corporate & In-House News

HSA Advocates elevates Aditya Khandelwal to Partnership

The Firm has also announced Associate-level promotions.

Bar & Bench

HSA Advocates has elevated Aditya Khandelwal to Partnership at the firm.

Khandelwal has over 13 years of experience in M&A, Banking & Finance, Capital Markets, and Securities Laws. He has advised clients across a wide range of contractual, transactional, financing, and regulatory matters. His professional focus encompasses infrastructure projects, PE investments, and providing support for India market entry, including navigating regulatory requirements.

HSA Advocates has also promoted Ishaan Duggal, Nipun Sharma, and Prithviraj Chauhan to the position of Associate Partner.

Ishaan Duggal, Nipun Sharma, and Prithviraj Chauhan

In addition to the Partner-level promotions, the firm has announced the elevation of the following attorneys:

  • Avi Yadav, Saurobroto Dutta, and Sourav Sharma have been promoted to Principal Associate.

  • Aasiya Khan, Jatin Batra, Nidhi Mahajan, Ruchi Goyal, and Shray Mehta have been promoted to Senior Associate.

Commenting on the promotions, Hemant Sahai, Founding Partner, said,

“At HSA Advocates, we firmly believe that the success of our people drives the success of our Firm. These promotions are a testament to the talent, dedication, and hard work of our colleagues. While we celebrate individual achievements, we also acknowledge the collective effort of the entire team, whose unwavering support and collaboration enable such excellence.”

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Students cannot be threatened for questioning, dissent is essential to democracy: Justice Ujjal Bhuyan

Why has no ‘distinguished jurist’ been made Supreme Court judge in 76 years? Justice Ujjal Bhuyan asks

Bhima Koregaon: Mumbai Court rejects NIA plea to cancel bail of four accused

Whitefield police station should be renamed darkfield: Karnataka HC flags repeated violation of arrest guidelines

Bombay High Court pulls up FDA for 'high-handed' cancellation of Cipla drug licences

SCROLL FOR NEXT